Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54
United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Mark Coleman
20 May 2025
Director
Sell
3,000
$107.49
$322.47K

What was left out

Form 4 filings counted 178
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 53
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,185,486
History held since 23 Nov 2015